Literature DB >> 18482004

Coupling transcription to RNA processing via the p68 DEAD box RNA helicase androgen receptor co-activator in prostate cancer.

Emma L Clark1, Frances V Fuller-Pace, David J Elliott, Craig N Robson.   

Abstract

The mechanisms involved in the transition from androgen-dependent to androgen-independent PCa (prostate cancer) remain largely undefined. The AR (androgen receptor) is an androgen-dependent transcription factor and is thought to play an important role in the development of both androgen-dependent and -independent prostatic malignancy. AR-mediated transcription is regulated by the binding of various cofactor proteins to the AR that facilitate transcriptional initiation and elongation. Elucidating the mechanisms by which cofactors regulate AR transcriptional activity may reveal the therapeutic potential of cofactors in PCa. Current models of gene expression indicate that transcription and RNA processing are tightly coupled. In this review, we discuss how the ATP-dependent DEAD box RNA helicase p68, which has established roles in transcription and RNA processing, may function as an 'adaptor' or coupling protein to facilitate cross-talk between transcription and RNA processing in AR-regulated genes by controlling the rate of transcriptional initiation/elongation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18482004     DOI: 10.1042/BST0360546

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  8 in total

Review 1.  Mechanisms of control of microRNA biogenesis.

Authors:  Brandi N Davis-Dusenbery; Akiko Hata
Journal:  J Biochem       Date:  2010-09-09       Impact factor: 3.387

2.  The expression of RNA helicase DDX5 is transcriptionally upregulated by calcitriol through a vitamin D response element in the proximal promoter in SiHa cervical cells.

Authors:  Ramiro José González-Duarte; Verna Cázares-Ordoñez; Lorenza Díaz; Víctor Ortíz; Fernando Larrea; Euclides Avila
Journal:  Mol Cell Biochem       Date:  2015-08-28       Impact factor: 3.396

3.  First-in-Class Phosphorylated-p68 Inhibitor RX-5902 Inhibits β-Catenin Signaling and Demonstrates Antitumor Activity in Triple-Negative Breast Cancer.

Authors:  Anna Capasso; Stacey M Bagby; Kyrie L Dailey; Naomi Currimjee; Betelehem W Yacob; Anastasia Ionkina; Julie G Frank; Deog Joong Kim; Christina George; Young B Lee; Ely Benaim; Brian Gittleman; Sarah J Hartman; Aik Choon Tan; Jihye Kim; Todd M Pitts; S Gail Eckhardt; John J Tentler; Jennifer R Diamond
Journal:  Mol Cancer Ther       Date:  2019-09-05       Impact factor: 6.261

4.  Proteomic analysis of phosphorylated nuclear proteins underscores novel roles for rapid actions of retinoic acid in the regulation of mRNA splicing and translation.

Authors:  Emilio J Laserna; M Luz Valero; Libia Sanz; Manuel M Sánchez del Pino; Juan J Calvete; Domingo Barettino
Journal:  Mol Endocrinol       Date:  2009-10-07

5.  The RNA helicase p68 is a novel androgen receptor coactivator involved in splicing and is overexpressed in prostate cancer.

Authors:  Emma L Clark; Anne Coulson; Caroline Dalgliesh; Prabhakar Rajan; Samantha M Nicol; Stewart Fleming; Rakesh Heer; Luke Gaughan; Hing Y Leung; David J Elliott; Frances V Fuller-Pace; Craig N Robson
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

6.  p68/DdX5 supports β-catenin & RNAP II during androgen receptor mediated transcription in prostate cancer.

Authors:  Emma L Clark; Christiana Hadjimichael; Richard Temperley; Amy Barnard; Frances V Fuller-Pace; Craig N Robson
Journal:  PLoS One       Date:  2013-01-17       Impact factor: 3.240

7.  The Ddx5 and Ddx17 RNA helicases are cornerstones in the complex regulatory array of steroid hormone-signaling pathways.

Authors:  Samaan Samaan; Léon-Charles Tranchevent; Etienne Dardenne; Micaela Polay Espinoza; Eleonora Zonta; Sophie Germann; Lise Gratadou; Martin Dutertre; Didier Auboeuf
Journal:  Nucleic Acids Res       Date:  2013-11-25       Impact factor: 16.971

8.  New Technologies Provide Quantum Changes in the Scale, Speed, and Success of SELEX Methods and Aptamer Characterization.

Authors:  Abdullah Ozer; John M Pagano; John T Lis
Journal:  Mol Ther Nucleic Acids       Date:  2014-08-05       Impact factor: 10.183

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.